A Rare Case of Large-Vessel Vasculitis following Checkpoint Inhibitor Therapy and Pegfilgrastim

Checkpoint inhibitors (CPIs) and pegfilgrastim, a long-acting growth factor agent, are vital components of current cancer treatments. Immune-related adverse events (irAEs) such as colitis and pneumonitis are well-established toxicities associated with CPI therapy. However, large-vessel vasculitis se...

Descripción completa

Detalles Bibliográficos
Autores principales: Mort, Joseph, Maheshwari, Shipra, Basu, Nayanika, Dillon, Patrick, Brady, Kevin, Bear, Harry, Millard, Trish
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8890883/
https://www.ncbi.nlm.nih.gov/pubmed/35251725
http://dx.doi.org/10.1155/2022/7295305

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8890883/
https://www.ncbi.nlm.nih.gov/pubmed/35251725
http://dx.doi.org/10.1155/2022/7295305

Ejemplares similares